Skip to main content

CORRECTION article

Front. Surg., 28 March 2023
Sec. Surgical Oncology

Corrigendum: CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis

\r\nHongyang Deng,&#x;Hongyang Deng1,†Jiaxing Zhang,&#x;Jiaxing Zhang2,†Yijun ZhengYijun Zheng1Jipin LiJipin Li1Qi XiaoQi Xiao1Fengxian WeiFengxian Wei1Wei HanWei Han1Xiaodong XuXiaodong Xu1Youcheng Zhang
\r\nYoucheng Zhang1*
  • 1Department of General Surgery, Hepatic-Biliary-Pancreatic Institute, Lanzhou University Second Hospital, Lanzhou, China
  • 2Key Laboratory of the Digestive System Tumors of Gansu Province, Lanzhou University Second Hospital, Lanzhou, China

A Corrigendum on

CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis

By Deng H, Zhang J, Zheng Y, Li J, Xiao Q, Wei F, Han W, Xu X, Zhang Y. (2023) Front. Surg. 10:878648. doi: 10.3389/fsurg.2022.878648

Text Correction

In the published article, there was an error. A text error occurred in the email address of correspondence.

A correction has been made to the email address of correspondence. This sentence previously stated:

zhangychmd@126.csom

The corrected sentence appears below: zhangychmd@126.com

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: coiled-coil domain containing 25, hepatocellular carcinoma, prognosis, diagnosis, immune infiltrates, ferroptosis

Citation: Deng H, Zhang J, Zheng Y, Li J, Xiao Q, Wei F, Han W, Xu X and Zhang Y (2023) Corrigendum: CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis. Front. Surg. 10:1175721. doi: 10.3389/fsurg.2023.1175721

Received: 28 February 2023; Accepted: 16 March 2023;
Published: 28 March 2023.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

© 2023 Deng, Zhang, Zheng, Li, Xiao, Wei, Han, Xu and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Youcheng Zhang zhangychmd@126.com

These authors have contributed equally to this work

Specialty Section: This article was submitted to Surgical Oncology, a section of the journal Frontiers in Surgery

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.